Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Neurology

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/BF00313739PMID 6191007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors associated with a rapid course of multiple sclerosis.

  1982cited by this paper
• MELSBROEK DISABILITY SCORING TEST

  1981cited by this paper
• Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.

  1980influential reference
• Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid.

  1980cited by this paper
• Relationships between abnormal IgG index, oligoclonal bands, acute phase reactants and some clinical data in multiple sclerosis

  1978cited by this paper
• Clinical picture of multiple sclerosis with late onset

  1978cited by this paper
• Multiple sclerosis

  1978cited by this paper
• The course of multiple sclerosis cases with extremely high gamma-globulin values in the cerebrospinal fluid.

  1977cited by this paper
• Studies on the natural history of multiple sclerosis--8. Early prognostic features of the later course of the illness.

  1977cited by this paper
• Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: disability, duration and age of onset.

  1976cited by this paper
• [Multiple sclerosis with reduced and with normal levels of complement in the blood. Clinical and genetic correlation].

  1976cited by this paper
• Letter: Transfer-factor therapy in multiple sclerosis.

  1973cited by this paper
• [Immunochemical estimation of IgG and albumin in cerebrospinal fluid].

  1972cited by this paper
• Étude quantitative des immunoglobulines G et de l'albumine du liquide cephalo rachidien

  1972cited by this paper
• Gel isoelectric focusing of cerebrospinal fluid proteins: a potential diagnostic tool

  1971cited by this paper
• Clinical factors determining prognosis in multiple sclerosis.

  1968cited by this paper
• On the problem of disease duration and invalidity in multiple sclerosis

  1966cited by this paper
• [On the problem of disease duration and invalidity in multiple sclerosis].

  1966cited by this paper
• PROGNOSTIC CRITERIA IN MULTIPLE SCLEROSIS

  1965cited by this paper
• Immunochemical quantitation of antigens by single radial immunodiffusion.

  1965cited by this paper
• PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

  1965cited by this paper

• Profile of Polish patients with primary progressive multiple sclerosis.

  2019cites this paper
• [Multiple sclerosis in the Altai region of Russia: a prospective epidemiological study].

  2019cites this paper
• Primary progressive multiple sclerosis in the Polish population

  2017cites this paper
• [Familial multiple sclerosis in Tomsk region].

  2016cites this paper
• No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients

  2015cites this paper
• Peculiarities of primary-progressive multiple sclerosis in the residents of volyn region

  2015cites this paper
• [The effect of genetic factors on the phenotypic expression of multiple sclerosis].

  2013cites this paper
• Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression

  2013cites this paper
• [Association between polymorphisms of cytokine genes and the rate of multiple sclerosis progression].

  2012cites this paper
• Long-term follow-up of clinical trials of multiple sclerosis therapies

  2011cites this paper
• Poor recovery after the first two attacks of multiple sclerosis is associated with poor outcome five years later.

  2010cites this paper
• ارزش پیشگوییکنندۀ CSF IgG در اسکلروز متعدد: مطالعه در 54 بیمار

  2008cites this paper
• Clinical , Laboratory and Radiological Predictors of Outcome in Relapsing Remitting Multiple Sclerosis

  2008cites this paper
• Prognostic value of intrathecal IgG synthesis in multiple sclerosis: a study in 54 patients

  2008cites this paper
• The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.

  2006cites this paper
• [Multiple sclerosis in ethnic groups of Bashkortostan Republic].

  2006cites this paper
• Benign course in multiple sclerosis: a review

  2006cites this paper
• Cytokines and intrathecal IgG synthesis in multiple sclerosis patients during clinical remission.

  2005cites this paper
• Mitoxantrone as a potential therapy for primary progressive multiple sclerosis

  2004cites this paper
• Intrathecal IgG synthesis: marker of progression in multiple sclerosis patients

  2002cites this paper
• Primary progressive multiple sclerosis: increasing clarity but many unanswered questions.

  2002cites this paper
• Short-term prognosis in early relapsing-remitting multiple sclerosis

  2000cites this paper
• Multiple sclerosis in Australia: prognostic factors.

  2000cites this paper
• Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors

  1999cites this paper
• A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials.

  1999cites this paper
• Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK

  1998cites this paper
• Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis.

  1997cites this paper
• Primary progressive multiple sclerosis: a distinct syndrome?

  1996cites this paper
• Defining the clinical course of multiple sclerosis

  1996cites this paper
• [Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors].

  1996cites this paper
• Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis.

  1995cites this paper
• Primary progressive versus relapsing remitting multiple sclerosis in Japanese patients: a combined clinical, magnetic resonance imaging and multimodality evoked potential study.

  1993cites this paper
• Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

  1993cites this paper
• Prognostic criteria in an epidemiological group of patients with multiple sclerosis: an exploratory study

  1992influential citation
• HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation.

  1991cites this paper
• Major differences in the dynamics of primary and secondary progressive multiple sclerosis

  1991cites this paper
• Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis.

  1990cites this paper
• Laboratory Investigation of Cerebrospinal Fluid Proteins

  1990cites this paper
• The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.

  1989cites this paper
• The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.

  1989cites this paper
• Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.

  1989cites this paper
• Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis

  1989cites this paper
• Prognostic relevance of initial clinical and paraclinical parameters for the course of multiple sclerosis.

  1988cites this paper
• Intrathecal Synthesis of Immunoglobulins in MS Patients

  1987cites this paper
• The Natural History of Multiple Sclerosis

  1987cites this paper
• Epidemiological investigations into multiple sclerosis in Southern Hesse. V. Course and prognosis

  1987cites this paper
• Multiple sclerosis – more than one disease?

  1985cites this paper
• Leu-3+ lymphocytes account for increased CSF cellularity.

  1985cites this paper
• A review of the etiology of multiple sclerosis

  1984cites this paper